BPC-157 + TB-500 + Cartalax
Also known as: BPC-157 / TB-500 / Cartalax blend, Tissue Repair Triple Blend
Pre-mixed three-peptide blend marketed for tissue repair and recovery, combining BPC-157 (a synthetic gastric-pentapeptide fragment), TB-500 (a synthetic Thymosin β4 fragment that promotes actin regulation and cell migration), and Cartalax (a synthetic Lys-Glu-Asp tripeptide, AED-related, marketed for cartilage and connective-tissue support). Each component is an individually grey-market research compound with no FDA-approved human indication; the blend itself has no published controlled human efficacy or safety data. Any rationale is inferred from preclinical and uncontrolled reports on the separate peptides, and combination-specific human data is lacking.
Common research uses
Pricing for BPC-157 + TB-500 + Cartalax
Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.
No sellers for BPC-157 + TB-500 + Cartalax are indexed yet — we add vendors and their prices as we find them.
COAs for BPC-157 + TB-500 + Cartalax
2 third-party tests across 2 vendors. Each card links to the full report.
Research use only — not for human consumption and not approved by the FDA. Nothing here is medical advice.